Informatics Services
To enhance our clinical trial studies, our experienced oncology bioinformatics team have developed a suite of informatics tools for oncology target identification and optimization. Our proprietary tools described below are also available as a service to enhance your oncology drug development programs. Please contact us for more information.
Informatics Platforms for
Oncology Target Identification
and Immunotherapy Optimization:
Two cutting-edge AI platforms developed and validated by our deep-benched, leading oncology informatics team for target identification:
NeoTCR® – for rapid identification of tumor reactive T-cells and TCR sequences using single cell sequencing data from tumor samples​ - validated across multiple cancer indications
​
NeoMiner® – for accurate identification of neoantigens using sequencing data from tumor samples - validated across multiple cancer indications
​
Deliverables:
High quality repertoire of tumor reactive T-cells and TCRs for your target indication
High quality panel of neoantigens for your target indication
